SCHEMBL465839

SCHEMBL465839

Cc1cc(Cl)cc2c(=O)oc(-c3cc(Br)nn3-c3ncccc3Cl)nc12

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 3/20 0.43
▸ CYP17A1 P05093 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MALT1 Q9UDY8 1/20 0.31
▸ TRPV1 Q8NER1 2/20 0.31
▸ ELANE P08246 1/20 0.30
▸ FABP3 P05413 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP2D6 P10635 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ FABP4 P15090 1/20 0.30
▸ FABP5 Q01469 1/20 0.30
▸ ABL1 P00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29598524 1.00 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL28531289 0.96 DHODH (0.41) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL29215063 0.93 DHODH (0.36) DHODHMAPTELANEFABP3CYP3A4
SCHEMBL21822337 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTTRPV1
SCHEMBL12528168 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTALDH1A1
SCHEMBL30560159 0.93 DHODH (0.43) DHODHCYP17A1CYP1A2MAPTTRPV1
SCHEMBL30466603 0.92 DHODH (0.44) DHODHCYP17A1CYP1A2TRPV1
SCHEMBL959396 0.92 DHODH (0.44) DHODHCYP17A1CYP1A2TRPV1
SCHEMBL950250 0.91 DHODH (0.40) DHODHMAPTALDH1A1POLBNPSR1
SCHEMBL30749778 0.91 DHODH (0.40) DHODHMAPTALDH1A1POLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3902792-B1 PROCESS FOR PREPARATION OF ANTHRANILAMIDES UPL LTD (IN) 2025-05-21 — — EP claimed
US-12331028-B2 Process for preparation of Anthranilamides UPL LTD (IN) 2025-06-17 — — US disclosed
EP-3902792-B1 PROCESS FOR PREPARATION OF ANTHRANILAMIDES UPL LTD (IN) 2025-05-21 — — EP disclosed
US-20240327395-A1 A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS TAGROS CHEMICALS INDIA PVT LTD (IN) 2024-10-03 — — US disclosed
US-20240279200-A1 PROCESS FOR PREPARATION OF ANTHRANILAMIDES UPL LTD (IN) 2024-08-22 — — US disclosed
CN-117700393-A Preparation method of chlorantraniliprole 青岛科技大学 2024-03-15 — — CN disclosed
US-20240067624-A1 PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES UPL LTD (IN) 2024-02-29 — — US disclosed
CN-117551091-A Synthetic method of chlorantraniliprole and intermediate thereof 青岛润农化工有限公司 2024-02-13 — — CN disclosed
US-20230382887-A1 PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE GHARDA CHEMICALS LIMITED (IN) 2023-11-30 — — US disclosed
US-20230382887-A1 PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE GHARDA CHEMICALS LIMITED (IN) 2023-11-30 — — US disclosed
US-20040209923-A1 Anthranilamide arthropodicide treatment FMC CORPORATION 2004-10-21 — — US disclosed
US-20040198984-A1 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides FMC CORPORATION 2004-10-07 — — US disclosed
EP-1427285-A1 ANTHRANILAMIDE ARTHROPODICIDE TREATMENT E. I. du Pont de Nemours and Company (US) 2004-06-16 — — EP disclosed
EP-1416797-A1 ARTHROPODICIDAL ANTHRANILAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-05-12 — — EP disclosed
EP-1416796-A1 METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-05-12 — — EP disclosed
WO-2004033468-A1 ANTHRANILAMIDE INSECTICIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-04-22 — — WO disclosed
WO-2004011447-A2 METHOD FOR PREPARING FUSED OXAZINONES FROM ORTHO-AMINO AROMATIC CARBOXYLIC ACID AND A CARBOXYLIC ACID IN THE PRESENCE OF A SULFONYL CHLORIDE AND PYRIDINE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-02-05 — — WO disclosed
WO-2003024222-A1 ANTHRANILAMIDE ARTHROPODICIDE TREATMENT E. I. DU PONT DE NEMOURS AND COMPANY (US) 2003-03-27 — — WO disclosed
WO-2003015519-A1 ARTHROPODICIDAL ANTHRANILAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-02-27 — — WO disclosed
WO-2003015518-A1 METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-02-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279200-A1 PROCESS FOR PREPARATION OF ANTHRANILAMIDES NAAA, ANTXR2, AADAC DHODH 466/4885CYP17A1 2061/4885CYP1A2 56/4885
US-20040209923-A1 Anthranilamide arthropodicide treatment ANTXR2, ARF5, NPM1 DHODH 1442/4885CYP17A1 2188/4885CYP1A2 455/4885
US-20240067624-A1 PROCESS FOR PREPARATION OF INSECTICIDAL ANTHRANILAMIDES ANTXR2, NAAA, AGPS DHODH 311/4885CYP17A1 1632/4885CYP1A2 26/4885
US-20230382887-A1 PROCESS FOR THE PREPARATION OF CHLORANTRANILIPROLE NPEPPS, PRLHR, ADCYAP1R1 DHODH 641/4885CYP17A1 951/4885CYP1A2 535/4885
US-20240327395-A1 A PROCESS FOR PREPARING BENZOXAZINONE COMPOUNDS XDH, PDHX, CYP11B1 DHODH 1384/4885CYP17A1 24/4885CYP1A2 55/4885
US-20040198984-A1 1-(3-halopyrid-2-yl)-3-substituted-5-((2,4-substituted-6-aminocarbonyl)phenylaminocarbonyl) pyrazoles insecticides CYP4B1, CYP1B1, CYP2E1 DHODH 2558/4885CYP17A1 1926/4885CYP1A2 16/4885
US-12331028-B2 Process for preparation of Anthranilamides NAAA, ANTXR2, AADAC DHODH 466/4885CYP17A1 2061/4885CYP1A2 56/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback